IMMUNOTAC
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88108634
- Registration number
- 6200968
- Mark type
- Stylized text
- Filed
- 07 Sept 2018
- Published for opposition
- 25 Feb 2020
- Registered
- 17 Nov 2020
- Attorney of record
- Joi A. White
Goods and services
- Class 005 — Pharmaceuticals: Systemically delivered, locally active immune modulatory conjugates in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; pharmaceuticals and pharmaceutical preparations of systemically delivered, locally active immune modulatory conjugates for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases; engineered immunomodulatory therapeutics in the nature of pharmaceuticals, including biopharmaceuticals, pharmaceutical preparations, including biopharmaceutical preparations, agents, namely, biopharmaceutical and pharmaceutical preparations and substances, and medicines for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases
Owner
- Silverback Therapeutics, Inc., Seattle, WA, US
- Silverback Therapeutics, Inc., Seattle, WA, US
- Silverback Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2020 — USE AMENDMENT FILED
- 22 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 21 Apr 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2020 — PUBLISHED FOR OPPOSITION
- 05 Feb 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jan 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jan 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE